Biochemical Markers of Bone Turnover in Rheumatoid Arthritis Patients Treated with Glucocorticoids

被引：0
|
作者：
Macovei, Luana Andreea [1 ]
Burlui, Alexandra [1 ]
Rezus, Elena [2 ]
机构：
[1] Grigore T Popa Univ Med & Pharm Iasi, Dept Rheumatol Rehabil Phys Med & Balneol, 16 Univ Str, Iasi 700115, Romania
[2] Clin Rehabil Hosp Iasi, Rheumatol Clin 1, 14 Pantelimon Halipa, Iasi 700656, Romania
来源：
REVISTA DE CHIMIE | 2019年 / 70卷 / 02期
关键词：
glucocorticoids; osteocalcin; deoxypyridinoline; BIOMARKERS; INTOXICATION; METABOLISM;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Osteocalcin and deoxypyridinoline levels were measured in 55 RA patients during and after glucocorticoid therapy with prednisone, methylprednisolone and cortisone. A decrease of 27% of the bone resorption marker deoxypyridinoline (from 10.13 to 7.4) and an increase of 23% of the bone formation marker osteocalcin (from 16.3 to 20.1) were also clinically confirmed by the presence of osteoporosis in 74% of patients receiving corticosteroid treatment as compared with only 31% in the control group.
引用
收藏
页码：623 / 626
页数：4
相关论文
共 50 条
  • [41] Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
    Riley, Thomas R.
    George, Michael D.
    RMD OPEN, 2021, 7 (01):
  • [42] Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids
    Devogelaer, Jean-Pierre
    Sambrook, Philip
    Reid, David M.
    Goemaere, Stefan
    Ish-Shalom, Sophia
    Collette, Julien
    Su, Guoqin
    Bucci-Rechtweg, Christina
    Papanastasiou, Philemon
    Reginster, Jean-Yves
    RHEUMATOLOGY, 2013, 52 (06) : 1058 - 1069
  • [43] Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty
    Nikolaus A. Streich
    Tobias Gotterbarm
    Martin Jung
    Ulrich Schneider
    Christian Heisel
    International Orthopaedics, 2009, 33 : 77 - 82
  • [44] Folate supplementation does not affect biochemical markers of bone turnover
    Herrmann, M
    Stanger, O
    Paulweber, B
    Hufnagl, C
    Herrmann, W
    CLINICAL LABORATORY, 2006, 52 (3-4) : 131 - 136
  • [45] Biochemical markers of bone turnover during growth hormone therapy
    Saggese, G
    Baroncelli, GI
    Barsanti, S
    PAEDIATRIC OSTEOLOGY: NEW DEVELOPMENTS IN DIAGNOSTICS AND THERAPY, 1996, 1105 : 235 - 239
  • [46] Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty
    Streich, Nikolaus A.
    Gotterbarm, Tobias
    Jung, Martin
    Schneider, Ulrich
    Heisel, Christian
    INTERNATIONAL ORTHOPAEDICS, 2009, 33 (01) : 77 - 82
  • [47] Glucocorticoids in the treatment of rheumatoid arthritis
    Bijlsma, J. W. J.
    Jacobs, J. W. G.
    Buttgereit, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : S34 - S36
  • [48] Biochemical bone turnover markers in diabetes mellitus - A systematic review
    Starup-Linde, Jakob
    Vestergaard, Peter
    BONE, 2016, 82 : 69 - 78
  • [49] Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids
    Stepan, JJ
    Havrdová, E
    Tyblová, M
    Horáková, D
    Tichá, V
    Nováková, I
    Zikán, V
    CLINICA CHIMICA ACTA, 2004, 348 (1-2) : 147 - 154
  • [50] Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study
    Mazzantini, Maurizio
    Talarico, Rosaria
    Doveri, Marica
    Consensi, Arianna
    Cazzato, Massimiliano
    Bazzichi, Laura
    Bombardieri, Stefano
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (11) : 2232 - 2236
12345